Merck & Co. - Rahway, NJ

Description:
Recently, R. Baker & Son was called upon by Merck & Co. to perform an extremely complex and intricate deconstruction project: to decommission, provide asset/investment recovery and dismantling of three bulk production plants. The challenge was to provide a seamless transition with no disruption of critical plant services that ran through and near buildings to be demolished.

A special program was used to identify services required to remain in place, design new supports where needed, and implement, system-by system and area-by-area, dismantling plans. This demonstrated to our client our complete understanding of what had to be done before any work was started.

The equipment in the building was decommissioned, cleaned, and rigged for market. Operational systems and services were re-supported, and the arduous task of manual selective dismantling was performed. Once the equipment was fully decommissioned, it was rigged out of the building through cooordinated access areas; the building was then entirely dismantled. During the project, we ensured that DI water, nitrogen, electrical systems, and other critical services supporting other buildings were unaffected. The project was executed exactly as required by Merck: as if we weren't even there.


Specs: Demolition, Selective Demolition, Rigging, Asset/Investment Recovery

Mannkind Pharmaceuticals - Danbury, CT

Description:
R. Baker & Son performed the selective demolition for Mannkind's Danbury, CT insulin manufacturing facility.

The demolition consisted of removing concrete slab, structural steel, elevators, exterior siding, loading docks, staircases, masonry walls; utilizing skid steers, walk-behind saws, mini-excavators equipped with scrubbers.

All work was performed while a portion of the building remained active. During this work air monitoring was performed on a daily basis.

Specs: Demolition, Environmental Services